Tram is an entrepreneurial non-executive director and former Fortune 50 C-level Executive with 28 years of leadership in technology-driven industries across five continents. Educated in Western and Anglo-Saxon environments, she has also nurtured a strong Asian cultural legacy that makes a difference in the boardroom. Sheis recognized for connecting the dots and bringing fresh international interdisciplinary collaboration and market expansion lenses powered by a diverse global network, governance, and market intelligence skills.
The breadth and depth of her experience come from having served in executive, advisory, and board leadership positions for varying-sized organizations, public and private, mid-sized family-owned businesses, and startups. As an inclusive leader, she has been interviewed and featured in four chapters of “The 5 Disciplines of Inclusive Leaders: Unleashing the Power of All of Us,” a book released by Korn Ferry in 2020.
Tram currently serves on a few public and private company boards, committed to advancing preventive healthcare with SaaS and deep technologies. She has also engaged as an Independent Director Affiliate member of the LPEA Luxembourg Private Equity Association adding governance insights to Private Equity-backed portfolio companies as well as continuously refreshing her directorship education with the PDA Private Directors Association and the NACD National Association of Corporate Directors.
As the founding chair of her private investment and acceleration holding Vitanlink, Tram has for the past 10 years, co-invested in pre-seed and supported SaaS and AI-driven companies as an advisor, board member and/or investor up to the post-seed and scaling stages in partnerships with accelerators, single family offices, VCs and PEs. She has consistently obtained a mentor rating of 9+ out of 10 from Endeavor Global Network of scale-ups CEOs.
PRIOR BOARD EXPERIENCE
Tram previously served as an executive member of the board of directors with an AI-powered wealth tech company. She was instrumental in recruiting a new CEO, repositioning the company from a B2B to a B2C AI product model, and led the company’s board decisions during the acquisition and transition into Synthetic Neural Labs Inc in 2021. She served as an independent lead board director for another emerging growth AI startup for the vision, where she helped the board connect to and acquire a Fortune100 listed US Group’s offer within 4 months
Tram added value as a member of the EMEA Executive Board for Welch Allyn Inc. mid-cap wholly owned by the Allyn family and since 2021 by Baxter International Inc (NYSE: BAX). She transformed the market, products, and channel models and closed an initial acquisition of the French entity by a European distributor that paved the way for future acquisitions.
Tram began her career as an auditor with EY, where she opened key offices in Vietnam and Cambodia before moving to J&J (NYSE: JNJ) Ortho-Clinic Diagnostics. She was awarded twice the Johnson & Johnson standards of leadership awards and she assumed increasing levels of P/L accountability, ultimately serving as a member of the EMEA management board. She expanded the international footprint for the $3 Billions JNJ’s IVD division.
Tram holds an MBA from McGill University, an active US Certified Public Accountant license [CPA New Hampshire State Board of Accounting], a certification in Private Company and Private Equity Portfolio Governance from the PDA, and the Financial Times Non-Executive Director Diploma.
Founding Vitanlink and leading each Portfolio Company to success
(I) AI health company selected top 5 in SXSW out of 2000 contenders, received a transaction offer $5 M from listed Fortune 100 MedTech and 20% stake within 4-month of incorporation.
(II) Award-winning co-founded AI fintech company sold to US holding and subsequent oversight of the new organization's global ecosystem of 6 continents and risks post-sale
Regional Distribution Model change for a $2B family-owned business, paving the way to the future acquisition by a buyer.
Enabled $70M opportunities detection for J&J OCD in China
Non-Executive Advisory Member, TenderHut SA (WSE: THG)
Fmr Executive Member, Johnson & Johnson OCD Regional EMEA Board (NYSE: JNJ)
Chair, Vitanlink, France
Board Member, Yoni Solutions, Switzerland
Advisory Member, The Sabi, Netherlands
Fmr Advisory Member, Thais Health Inc. US
Fmr Advisory Member, Droon France
Fmr Director DreamUp Vision, France
Fmr Executive Director, AI Fintech QuantsUnited
Fmr Executive Board Member, WelchAllyn Inc Regional EMEA Board, US family-owned business
Fmr Non-Executive Advisory Member, EU Commission
BOARD ASSETS & SECTORS
International Channel & Market Expansion
Corporate & Advisory Board Governance
Revenue & EBITDA growth
Venture Capital and Private Equity
LPEA Luxembourg Private Equity Association
BCFL Business Club France Luxembourg
NACD National Association of Corporate Directors
PDA Private Directors Association
IPEL Ivy Plus European Leaders
AI Deep Learning
AI Machine Learning
The word around town
Co-Founder & CEO
Thaïs Health Inc
Single Family Office
'When Tram Trinh sits on a Board she is always active in providing solutions, ideas to support companies’ growth.
I highly recommend her'
Paris, France, 2020
Health Futures Forum
'Tram is an inspiring thought leader and an excellent facilitator'
London, UK, 2020
Board Member, Former Corporate Senior VP
'Tram has all the personal values that I live by: passion for what she does, full commitment with truth and reality, integrity, loyalty, [..] and a serving leadership vocation'
Lausanne, Suisse, 2020
Managing Director, Rouge International
'Tram’s dedication to developing, encouraging, and providing exposure for her portfolio companies as an entrepreneur, investor, advisor, and board member is unparalleled' [..]
Hong Kong, HK SAR, 2022
Hospital MD, President
'I have been working with Tram for more than ten years during which we shared complex situations related to the healthcare sector. What I always appreciate is her ability to think globally and locally [..]'
Bordeaux, France, 2022